Jan 112016
 

SFGate
Pricey hepatitis C drugs threaten health care system
SFGate
After examining 20,000 pages of internal company documents, looking at Medicaid data and interviewing health care experts, the authors concluded that the Foster City-based drugmaker “pursued a calculated scheme for pricing and marketing its hepatitis C …

and more »